Stock Ticker

  • Loading stock data...

Mylan Inc. (NASDAQ:MYL) Manages license Agreement With Pfizer Inc. (NYSE:PFE) For Generic Version Of Celebrex

Boston, MA 06/04/2014 (wallstreetpr) – Mylan Inc. (NASDAQ:MYL) made an official announcement about its license agreement to sell the generic version of the painkiller capsules Celecoxib, also referred popularly as Celebrex, with Pfizer Inc. (NYSE:PFE). Abbreviated New Drug Application (ANDA) In answer to the aforementioned application made by Mylan Inc. (NASDAQ:MYL) to the US FDA, […]